In the News

House Ways & Means Health Subcommittee hearing: Lowering Costs for Patients: The Health of the Biosimilar Market
Biosimilars Council Executive Director Craig Burton Testifies before Congress on Biosimilars Crisis
April 8, 2025
Report: A Decade of Biosimilars and Barriers Remain
March 5, 2025
Biosimilar Void is a Crisis in Patient Access According to IQVIA Report
February 3, 2025
AAM Comments on End of Year Funding Bill
December 18, 2024
white house
AAM & Biosimilars Council Statement on Presidential Election
November 7, 2024
Capitol at sunet, biosimilar legislation
Biosimilars Council Urges House to Pass Critical Patent Thicket Legislation
September 20, 2024

Filter by Keyword

Filter by Audience

Filter by Category

Filter by Keyword

Filter by Issue

Filter by Category

MENU